drugset / Trial / NCT00975091
Continue Entecavir Rollover From China
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to determine if treatment with entecavir is safe and well tolerated in patients who completed dosing in a previous entecavir study in China, but are requiring further treatment of their chronic hepatitis B virus infection.
Timeline
- Start
- 2004-05
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Entecavir | Small molecule | 0.5 mg | Oral |
| Comparator | Entecavir | Small molecule | 1 mg | Oral |